Name: Name:2-methyl-1,5-naphthyridine
Brand: AABLOCKS
SKU: AA0036FV
Rating: 90 (10 reviews)

Technical Information

Catalog Number: AA0036FV

Chemical Name: 2-methyl-1,5-naphthyridine

CAS Number: 7675-32-3

Molecular Formula: C9H8N2

Molecular Weight: 144.1732

MDL Number: MFCD07437992

SMILES: Cc1ccc2c(n1)cccn2

Properties

BP: 252.8°C at 760 mmHg

Form: Solid

MP: 62℃

Storage: Keep in dry area;Room Temperature;

Complexity: 136

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 11

Hydrogen Bond Acceptor Count: 2

Hydrogen Bond Donor Count: 0

Isotope Atom Count: 0

Rotatable Bond Count: 0

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 1.6

Downstream Synthesis Route

764717-61-5

7675-32-3

[1]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1942,vol.62,p.257,265;dtsch.Ref.S.66 Chem.Abstr.,1951,p.2950

5-Amino-2-methylpyridine

56-81-5

7675-32-3

[1]Gellibert,Françoise;Woolven,James;Fouchet,Marie-Hélène;Mathews,Neil;Goodland,Helen;Lovegrove,Victoria;Laroze,Alain;Nguyen,Van-Loc;Sautet,Stéphane;Wang,Ruolan;Janson,Cheryl;Smith,Ward;Krysa,Gaël;Boullay,Valérie;DeGouville,Anne-Charlotte;Huet,Stéphane;Hartley,David[JournalofMedicinalChemistry,2004,vol.47,#18,p.4494-4506]

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-US2006/84673,2006,A1Locationinpatent:Page/Pagecolumn7

[3]CurrentPatentAssignee:CALYGENEBIOTECHNOLOGY;CALYGENEBIOTECHNOLGY-WO2018/208630,2018,A1Locationinpatent:Page/Pagecolumn55

[4]CurrentPatentAssignee:SYNTHISTHERAPEUTICS;SYNTHIS-WO2020/13803,2020,A1Locationinpatent:Paragraph0138-0142

[5]CurrentPatentAssignee:SYNTHISTHERAPEUTICS-US2020/147234,2020,A1Locationinpatent:Paragraph0155-0158

[6]CurrentPatentAssignee:SYNTHIS;SYNTHISTHERAPEUTICS-WO2020/256751,2020,A1Locationinpatent:Paragraph0144-0147

[7]CurrentPatentAssignee:SYNTHISTHERAPEUTICS-WO2021/142086,2021,A1Locationinpatent:Paragraph0147-0150

[8]CurrentPatentAssignee:SumitomoPharma(in:SumitomoChemical);SumitomoChemical(w/oDongwooFine-Chem);SUMITOMOCHEMICALCOMPANYLIMITED-WO2011/150156,2011,A2Locationinpatent:Page/Pagecolumn127

[9]CurrentPatentAssignee:HUTCHISONMEDIPHARMALTD;HUTCHISONCHINAMEDITECHLTD.-US2012/245178,2012,A1Locationinpatent:Page/Pagecolumn32

7675-32-3

13602-11-4

446297-56-9

[1]JournalofMedicinalChemistry,2004,vol.47,p.4494-4506

[2]Patent:WO2020/13803,2020,A1.Locationinpatent:Paragraph0139;0143-0145

7675-32-3

2524-52-9

446297-54-7

[1]Gellibert,Françoise;Woolven,James;Fouchet,Marie-Hélène;Mathews,Neil;Goodland,Helen;Lovegrove,Victoria;Laroze,Alain;Nguyen,Van-Loc;Sautet,Stéphane;Wang,Ruolan;Janson,Cheryl;Smith,Ward;Krysa,Gaël;Boullay,Valérie;DeGouville,Anne-Charlotte;Huet,Stéphane;Hartley,David[JournalofMedicinalChemistry,2004,vol.47,#18,p.4494-4506]

7675-32-3

451-46-7

764717-64-8

[1]Gellibert,Françoise;Woolven,James;Fouchet,Marie-Hélène;Mathews,Neil;Goodland,Helen;Lovegrove,Victoria;Laroze,Alain;Nguyen,Van-Loc;Sautet,Stéphane;Wang,Ruolan;Janson,Cheryl;Smith,Ward;Krysa,Gaël;Boullay,Valérie;DeGouville,Anne-Charlotte;Huet,Stéphane;Hartley,David[JournalofMedicinalChemistry,2004,vol.47,#18,p.4494-4506]

Literature fold

Title: A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium.

Journal: The Journal of antibiotics20110201

Title: Conformational change of elongation factor Tu (EF-Tu) induced by antibiotic binding. Crystal structure of the complex between EF-Tu.GDP and aurodox.

Journal: The Journal of biological chemistry20010518

7675-32-3 | 2-methyl-1,5-naphthyridine